Serum interleukin-21 level in patients with severe adverse cutaneous drug reactions and correlation with disease severity - Egyptian Knowledge Bank - troweb

370181

Serum interleukin-21 level in patients with severe adverse cutaneous drug reactions and correlation with disease severity

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

Serum level of interleukin-22 in patients with psoriasis and its correlation with disease severity

Article

Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata

Article

Serum Interlukin-22 in Psoriasis Vulgaris

Article

Correlation between Serum Interleukin-31 Level and the Severity of Atopic Dermatitis in Children

Article

Assessment of Serum Interleukin-23 in Acne Vulgaris Patients and Its Correlation with Disease Severity

Article

INTERLEUKIN 23 AND INTERLEUKIN17 IN PSORIASIS, ATOPIC DERMATITIS AND LICHEN PLANUS: A SEROLOGICAL STUDY

Article

Serum Level of Interleukin-2 and Renal Involvement in Lupus Erythematosus Patients

Article

Serum Interleukin 18 and NLRP3 in patients with Alopecia Areata

Article

Serum Interleukin 19 in Patients with Vitiligo

Article

Serum Interleukin 19 in Patients with Alopecia Areata